These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16469271)

  • 21. Gene therapy prospects for Duchenne muscular dystrophy.
    Clemens PR; Caskey CT
    Eur Neurol; 1994; 34(4):181-5. PubMed ID: 8082675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for muscular dystrophy: molecular medicines entering the clinic.
    Bushby K; Lochmüller H; Lynn S; Straub V
    Lancet; 2009 Nov; 374(9704):1849-56. PubMed ID: 19944865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The physiological evaluation of gene therapies of dystrophin-deficient muscles.
    Gillis JM; Deconinck N
    Adv Exp Med Biol; 1998; 453():411-6; discussion 417. PubMed ID: 9889852
    [No Abstract]   [Full Text] [Related]  

  • 24. The Pathogenesis and Therapy of Muscular Dystrophies.
    Guiraud S; Aartsma-Rus A; Vieira NM; Davies KE; van Ommen GJ; Kunkel LM
    Annu Rev Genomics Hum Genet; 2015; 16():281-308. PubMed ID: 26048046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging strategies for cell and gene therapy of the muscular dystrophies.
    Muir LA; Chamberlain JS
    Expert Rev Mol Med; 2009 Jun; 11():e18. PubMed ID: 19555515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular targets to treat muscular dystrophies.
    Kinter J; Sinnreich M
    Swiss Med Wkly; 2014 Feb; 144():w13916. PubMed ID: 24554202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy for muscular dystrophy: moving the field forward.
    Al-Zaidy S; Rodino-Klapac L; Mendell JR
    Pediatr Neurol; 2014 Nov; 51(5):607-18. PubMed ID: 25439576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene and Cell Therapy for Muscular Dystrophies: Are We Getting There?
    Galli F; Bragg L; Meggiolaro L; Rossi M; Caffarini M; Naz N; Santoleri S; Cossu G
    Hum Gene Ther; 2018 Oct; 29(10):1098-1105. PubMed ID: 30132372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy of Duchenne muscular dystrophy.
    Fassati A; Murphy S; Dickson G
    Adv Genet; 1997; 35():117-53. PubMed ID: 9348647
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene therapy research for Duchenne and Becker muscular dystrophies.
    Karpati G; Gilbert R; Petrof BJ; Nalbantoglu J
    Curr Opin Neurol; 1997 Oct; 10(5):430-5. PubMed ID: 9330891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in genome editing technologies for treating muscular dystrophy.].
    Makita Y; Hozumi H; Hotta A
    Clin Calcium; 2017; 27(3):391-399. PubMed ID: 28232654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duchenne muscular dystrophy.
    Dickson G; Brown SC
    Mol Cell Biol Hum Dis Ser; 1995; 5():261-80. PubMed ID: 9532571
    [No Abstract]   [Full Text] [Related]  

  • 34. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
    Wang Z; Kuhr CS; Allen JM; Blankinship M; Gregorevic P; Chamberlain JS; Tapscott SJ; Storb R
    Mol Ther; 2007 Jun; 15(6):1160-6. PubMed ID: 17426713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystrophin and muscular dystrophy: past, present, and future.
    O'Brien KF; Kunkel LM
    Mol Genet Metab; 2001; 74(1-2):75-88. PubMed ID: 11592805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of Duchenne muscular dystrophy: past, present, and future.
    Davies KE; Tinsley JM; Blake DJ
    Ann N Y Acad Sci; 1995 Jun; 758():287-96. PubMed ID: 7625698
    [No Abstract]   [Full Text] [Related]  

  • 37. Duchenne muscular dystrophy.
    Chamberlain JS
    Curr Opin Genet Dev; 1991 Jun; 1(1):11-4. PubMed ID: 1840869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic therapeutic approaches for Duchenne muscular dystrophy.
    Foster H; Popplewell L; Dickson G
    Hum Gene Ther; 2012 Jul; 23(7):676-87. PubMed ID: 22647146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human dystrophin gene transfer: genetic correction of dystrophin deficiency.
    Dickson G; Dunckley M
    Mol Cell Biol Hum Dis Ser; 1993; 3():283-302. PubMed ID: 8111543
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy.
    Wells DJ; Wells KE; Asante EA; Turner G; Sunada Y; Campbell KP; Walsh FS; Dickson G
    Hum Mol Genet; 1995 Aug; 4(8):1245-50. PubMed ID: 7581360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.